Table 2 |
|||||||||||||
|
Results of the best SNPs in SH3PXD2B, SLIT3 and FLJ42133 as previously described [6] in two independent GWAs. |
|||||||||||||
|
Case-control1 |
KORA cohort2 |
||||||||||||
|
|
|
||||||||||||
|
Gene |
SNP |
Alleles3 |
MAF4 cases/controls |
Genotype distribution cases (%)/controls (%) |
Odds ratio (95% CI) |
Two-sided p-value |
One-sided p-value |
MAF |
β (95% CI) |
Two-sided p-value |
One-sided p-value |
||
|
|
|
||||||||||||
|
SH3PXD2B |
rs13356223 |
T/C |
0.033/ 0.032 |
454 (93.4)/ 410 (93.8) |
32(6.6)/ 26 (6.0) |
0/ 1 (0.2) |
1.029 (0.614 – 1.722) |
0.915 |
0.457 |
0.041 |
-0.549 (-1.235 – 0.136) |
0.116 |
0.942 |
|
rs10077897 |
G/A |
0.040/ 0.036 |
447 (92.0)/ 411 (93.0) |
39 (8.0)/ 30 (6.8) |
0/ 1 (0.2) |
1.114 (0.690 – 1.799) |
0.658 |
0.329 |
0.046 |
-0.430 (-1.086 – 0.225) |
0.198 |
0.901 |
|
|
rs13436547 |
G/A |
0.033/ 0.032 |
455 (93.4)/ 415 (93.9) |
32 (6.6)/ 26 (5.9) |
0/ 1 (0.2) |
1.038 (0.620 – 1.739) |
0.886 |
0.443 |
0.041 |
-0.486 (-1.172 – 0.201) |
0.165 |
0.917 |
|
|
SLIT3 |
rs17734503 |
A/G |
0.082/ 0.072 |
409 (84.0)/ 380 (86.0) |
76 (15.6)/ 60 (13.6) |
2 (0.4)/ 2 (0.4) |
1.150 (0.814 – 1.626) |
0.428 |
0.214 |
0.086 |
0.358 (-0.109 – 0.825) |
0.133 |
0.066 |
|
rs12654448 |
C/T |
0.079/ 0.071 |
410 (84.4)/ 381 (86.2) |
75 (15.4)/ 59 (13.3) |
1 (0.2)/ 2 (0.5) |
1.126 (0.791 – 1.602) |
0.510 |
0.255 |
0.088 |
0.125 (-0.352 – 0.601) |
0.608 |
0.304 |
|
|
FLJ42133 |
rs7363432 |
A/G |
0.066/ 0.070 |
424 (87.1)/ 383 (86.6) |
62 (12.7)/ 56/(12.7) |
1 (0.2)/ 3 (0.7) |
0.932 (0.649 – 1.340) |
0.704 |
0.648 |
0.057 |
0.234 (-0.369 – 0.837) |
0.447 |
0.223 |
|
rs6095722 |
A/G |
0.066/ 0.070 |
422 (87.0)/ 383 (86.6) |
62 (12.8)/ 56/(12.7) |
1 (0.2)/ 3 (0.7) |
0.936 (0.651 – 1.346) |
0.722 |
0.639 |
0.060 |
0.134 (-0.447 – 0.715) |
0.651 |
0.325 |
|
|
|
|||||||||||||
|
1 described in Hinney et al., 2007 [7] 2 described in Wichmann et al., 2008 [8] 3 minor allele in bold 4MAF = minor allele frequency |
|||||||||||||
|
Vogel et al. BMC Medical Genetics 2009 10:14 doi:10.1186/1471-2350-10-14 |
|||||||||||||